← Back to Dashboard

Truvada

Dual NRTI

Constituent drugs (2)

Emtricitabine

Could not render structureView on PubChem
3D not available

Tenofovir Disoproxil

Could not render structureView on PubChem
3D not available

Chemical Identifiers

Clinical Development by Virus1

Human immunodeficiency virus 1
HIV-1
Target: Viral RT
Approved (other)
Preclinical
Phase 2positive
Phase 3positive
Approved
Japan
Approval ref (kegg.jp) Approval ref (pmda.go.jp) PMDA approved 2005/3/23fixed-dose combination of Emtricitabine, Tenofovir disoproxil.